Conditional ablation of TGF-β signaling inhibits tumor progression and invasion in an induced mouse bladder cancer model.
Yu Liang, Fengyu Zhu, Haojie Zhang, Demeng Chen, Xiuhong Zhang, Qian Gao, Yang Li
Index: Sci. Rep. 6 , 29479, (2016)
Full Text: HTML
Abstract
The role of transforming growth factor-β (TGF-β) signaling in cancer progression is still under debate. To determine the function of TGF-β signaling in bladder cancer progression, we conditionally knocked out the Tgfbr2 in mouse model after a N-butyl-N-4-hydroxybutyl Nitrosamine induced bladder carcinogenesis. We found the ablation of TGF-β signaling could inhibit the cancer cell proliferation, cancer stem cell population and EMT, hence suppressed the invasive cancer progression, which is similar with the result of TGF-β receptor I inhibitor treatment. These findings recognize the roles and mechanisms of TGF-β signaling in bladder cancer progression in vivo for the first time.
Related Compounds
Related Articles:
2003-09-11
[J. Med. Chem. 46 , 3953-3956, (2003)]
2006-03-23
[J. Med. Chem. 49 , 2138-2142, (2006)]
2003-12-15
[Bioorg. Med. Chem. Lett. 13 , 4355-4359, (2003)]
2006-11-10
[J. Biol. Chem. 281 , 33971-33981, (2006)]
2014-06-01
[Exp. Eye Res. 123 , 72-86, (2014)]